News from NIAID-Supported Institutions

News from NIAID-Supported Institutions

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Point-of-Care CD4 Testing is Economically Feasible for HIV Care in Resource-Limited Areas 
September 16, 2014—Massachusetts General Hospital

ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding 
September 16, 2014—ContraFect Corporation

Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine 
September 15, 2014—The Scripps Research Institute

 

New Insights in Survival Strategies of Bacteria  
September 14, 2014—VIB (the Flanders Institute for Biotechnology)
 

Geneva & Partners in Development of Ebola Drug 
September 12, 2014—The Geneva Foundation

 

Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice 
September 11, 2014—Emory University

 

PharmAthene Awarded Contract of Up to $28.1 Million to Develop Next Generation Thermostable Anthrax Vaccine  
September 10, 2014—PharmAthene, Inc.
 

Study Sheds Light on Asthma and Respiratory Viruses  
September 9, 2014—Washington University School of Medicine in St. Louis
 

Unusual Immune Cell Needed to Prevent Oral Thrush, Pitt Researchers Find 
September 8, 2014—University of Pittsburgh School of Medicine
 

Suppressing Food Allergies Quickly Is the Goal of UC Research Team 
September 8, 2014—University of Cincinnati College of Medicine

Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine 
September 8, 2014—Emergent BioSolutions Inc.

 

Team Identifies Important Regulators of Immune Cell Response  
September 8, 2014—The Scripps Research Institute

 

MCW Scientists to Investigate New Therapy for Obstructive Lung Disease 
September 4, 2014—The Medical College of Wisconsin

Avian Influenza Virus Isolated in Harbor Seals Poses a Threat to Humans 
September 4, 2014—St. Jude Children’s Research Hospital

 

Johnson & Johnson Responds to Ebola Crisis with Commitment to Accelerate Vaccine Program in Collaboration with the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid  
September 4, 2014—Johnson & Johnson

Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health 
September 4, 2014—Bavarian Nordic

 

Leaky Gut—A Source of Non-AIDS Complications in HIV-Positive Patients 
September 3, 2014—Case Western Reserve University School of Medicine

 

Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine  
September 2, 2014—Soligenix, Inc.

Biochemists Find New Treatment Options for Staph Infections, Inflammatory Diseases 
September 2, 2014—Kansas State University

War Between Bacteria and Phages Benefits Humans  
September 2, 2014—Tufts University